Seeing Is Believing
Healthcare - Sector
with an average price target of $8.63. This is a potential upside of $7.33 (563.85%) from yesterday's end of day stock price of $1.3.
Zynerba Pharmaceuticals's activity chart (see below) currently has 58 price targets and 54 ratings on display.
Analysts average stock forecasts to be materialized ratio is 13.94% with an average time for these price targets to be met of 87.58 days.
Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 16-Aug-2023. First documented stock forecast 31-Aug-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Apr-2019
$1.11
$-0.19 (-14.62%)
2 years 7 months 23 days ago
(16-Aug-2023)
0/6 (0%)
$-0.18 (-13.95%)
Buy Since 07-Oct-2016
$23
2 years 7 months 24 days ago
(15-Aug-2023)
0/2 (0%)
$11.13 (93.77%)
Buy Since 14-Nov-2017
$8
4 years 8 months 6 days ago
(02-Aug-2021)
2/9 (22.22%)
$3.99 (99.50%)
113
Buy Since 31-Dec-2019
$7.25
$5.95 (457.69%)
$8.5
5 years 29 days ago
(10-Mar-2021)
1/4 (25%)
$2.91 (67.05%)
225
Buy Since 05-Jul-2018
$9
$7.7 (592.31%)
5 years 3 months 18 days ago
(21-Dec-2020)
0/4 (0%)
$5.56 (161.63%)
What is ZYNE (Zynerba Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ZYNE (Zynerba Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ZYNE (Zynerba Pharmaceuticals)?
Which analyst is the currently most bullish on ZYNE (Zynerba Pharmaceuticals)?
Which analyst is the currently most reserved on ZYNE (Zynerba Pharmaceuticals)?